ArticleThe Journal of pathology2019

TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target.

Lin-Yu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.